Physitrack Q3 2023: Preview - Redeye
Physitrack will release its Q3 2023 report on 14 November at 08:00 and host a conference call at 10:00. We anticipate a solid quarter with c24% y/y organic growth and margin improvements. The prevailing situation from Q2 is expected to remain unchanged, with a continued focus on high-margin customers, resulting in a modestly restrained top-line performance while improving margins in Q3’23. Additionally, we anticipate that the Q3’23 results will reaffirm Physitrack’s progress toward achieving positive cash flow by Q4’23. At this time, we are reiterating our fair value range, with a base case of SEK41 per share.
Länk till analysen i sin helhet: https://www.redeye.se/research/955543/physitrack-q3-2023-preview?utm_source=finwire&utm_medium=RSS